About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials Prostate CancerMassachusetts

Prostate Cancer Clinical Trials in Massachusetts

Find 507 clinical trials for prostate cancer near Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Massachusetts

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 507 trials

CompletedBicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate CancerThe purpose of this trial is to study the effect - in terms of time to progression and overall survival - of 2 years of adjuvant bicalutamide 150mg monotherapy, versus placebo, in…NCT00657904·Birmingham, Alabama and 84 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of JNJ-101556143 in Participants With Metastatic Prostate CancerThe purpose of this study is to evaluate how well JNJ-101556143 works in participants with metastatic androgen pathway modulation-resistant prostate cancer (mAPMR), an advanced…NCT07832292·Largo, Florida and 13 others

CompletedA Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate CancerThe purpose of this study is to look at the effects (good and bad) of the combination of docetaxel and carboplatin for patients who have progressive prostate cancer after…NCT00134706·Boston, Massachusetts and 5 others

CompletedPersonal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care NetworksThe purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how…NCT01844999·Downey, California and 3 others

CompletedRadiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyRATIONALE: Specialized radiation therapy that delivers a high-dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.NCT00528866·Phoenix, Arizona and 69 others

CompletedGemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerThis randomized phase III trial studies gemcitabine hydrochloride, cisplatin, and bevacizumab to see how well they work compared with gemcitabine hydrochloride and cisplatin in…NCT00942331·Birmingham, Alabama and 872 others

CompletedZoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone InvolvementThis randomized phase III trial studies two different schedules of zoledronic acid to compare how well they work in reducing bone-related complications in patients with breast…NCT00869206·Fairbanks, Alaska and 503 others

Active not recruitingEnzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate CancerThe purpose of this study is to determine the effectiveness of enzalutamide as part of adjuvant androgen deprivation therapy (ADT) with a luteinizing hormone releasing hormone…NCT02446444·Boston, Massachusetts and 68 others

TerminatedATR Inhibitor Elimusertib (BAY1895344) Plus Niraparib Phase 1b Study in Advanced Solid Tumors and Ovarian CancerThe purpose of the study is to test how well patients with advanced solid tumors and ovarian cancer respond to treatment with elimusertib in combination with niraparib.NCT04267939·Boston, Massachusetts and 2 others

Active not recruitingA Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate CancerThis study is being done to see how safe and effective abemaciclib is when given together with abiraterone acetate plus prednisone in participants with metastatic castration…NCT03706365·Phoenix, Arizona and 111 others

CompletedGenetic Testing for Breast, Ovarian, Pancreatic, and Prostate CancersThis study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.NCT04330716·Boston, Massachusetts and 5 others

CompletedCholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate CancerThis randomized phase II trial studies cholecalciferol and genistein compared to placebo in treating patients with early stage prostate cancer.NCT01325311·Birmingham, Alabama and 10 others

CompletedMifepristone (RU-486) in Androgen Independent Prostate CancerThe purpose of this study is to determine the effects (good and bad) that mifepristone has on patients with androgen independent prostate cancer.NCT00140478·Washington D.C., District of Columbia and 3 others

CompletedOnce-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.The goal of this clinical study is to determine the efficacy and safety of Seviteronel, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist, in patients with…NCT02445976·Birmingham, Alabama and 20 others

CompletedPersonal Web Page In Clinical Trial Participant EducationThis research study is evaluating the effectiveness of video and web-based communication in clinical research compared to standard practices.NCT03887091·Boston, Massachusetts

TerminatedSunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel ChemotherapyThis study will compare the safety and efficacy of sunitinib in combination with prednisone versus placebo and prednisone in patients that have metastatic castration-resistant…NCT00676650·Decatur, Alabama and 204 others

CompletedMobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation TherapyThis research study seeks to develop and evaluate a mobile health app which aims to provide patients who are about to initiate androgen deprivation therapy for prostate cancer…NCT03761160·Boston, Massachusetts

Active not recruitingTesting Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate CancerThis randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with castration-resistant prostate cancer that has spread to other…NCT02893917·La Jolla, California and 15 others

CompletedA Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerThis is a multi-center open-label dose-escalation study of a novel compound (MDV3100) to treat patients with castration-resistant (hormone-refractory) prostate cancer.NCT00510718·Boston, Massachusetts and 8 others

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

PreviousPage 2 of 26Next

Other Conditions in Massachusetts

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma